Newsletter | April 17, 2025

04.17.25 -- Progress Report: Advancements In IDMP Readiness Efforts

SPONSOR

The biotechnology sector is transforming with AI, automation, and digitalization playing key roles in drug development and manufacturing. As the industry moves toward end-to-end digitalization, don't miss the opportunity to join the 2025 ISPE Biotechnology Conference, 2 – 3 June in Boston, Massachusetts, USA, and virtually, to gain a holistic perspective on how to view and apply digital transformation in biopharmaceutical manufacturing. Register today

INDUSTRY INSIGHTS

GMP Annex 1 For Sterile Manufacturing In The EU

The revised EU GMP Annex 1 mandates a comprehensive Contamination Control Strategy, continuous environmental monitoring, and species-level contaminant identification to ensure compliance.

Is Lipinski's Rule Of Five Still Relevant In Drug Development?

Some drugs violate multiple Ro5 elements but remain developable, while some molecules adhere strictly to the Ro5, but their properties are not conducive to development.

Particle Size Control Through Micronization: Challenges And Solutions

What technical issues need to be addressed if an API is to be successfully micronized? Explore a robust process development strategy that ensures all attributes critical for quality are maintained.

Bypassing The Challenges Of Paper-Based Validation

Delve into why a biotechnology startup and CDMO views investment in a digitized validation lifecycle management system as crucial for accelerating innovation and reducing time to market.

Outlining The Trends And Challenges In The Inhaled Drug Delivery Market

Discover the latest trends and solutions in inhaled drug delivery, with a focus on overcoming dry powder formulation challenges to advance next-generation therapeutics.

Connecting Quality Management, Patient-Centricity, And Business Value

Examine why organizations must integrate data and processes to enhance quality and insights to improve operational efficiency, patient health, and regulatory compliance.

Streamlining 3D Cancer Assays With Automated Innovations

Gain insight into the use of 3D cultured cancer models in the search for new therapies for complex diseases like cancer.

Getting More From Your Buffer Management Strategy

A drug manufacturer was facing challenges in buffer management. By implementing innovative inline buffer formulation technology, they were able to save space and increase efficiency.

Use High-Content Imaging To Drive Small Molecule Protein Degraders

Find out how a cost-effective high-content immunofluorescence workflow using the Revvity Opera Phenix™ system efficiently identifies small molecule protein degraders with multi-dimensional data.

How To Unlock The Secret To Repeatable, Scalable Low Turnover

Review the evolution of a 10-year partnership and extrapolate the principles that create cohesive teams and minimize turnover.

How A Pharma Company Improved Yield By 1.5% In Just Three Months

A pharma company faced a 4% yield drop and variability at a manufacturing facility. See how they leveraged an AI-based platform to unify data, pinpoint inefficiencies, and enhance consistency in yields.

Late-Stage Serialization Customization: A Key Differentiator For CDMOs

CMOs and CPOs currently face significant challenges, including strong competition, high cost pressure, and more. Learn why being agile, flexible, and responsive is bound to pay off.

FEATURED EDITORIAL

Survey Findings: How Are IDMP Readiness Efforts Progressing?

ISO Identification of Medicinal Products (IDMP) standards were designed to harmonize the way the life sciences industry records and manages data about its products. Companies’ state of readiness to implement and harness IDMP still varies.

SOLUTIONS

Easy-To-Use 1 mL Disposable Autoinjector

Process Lifecycle Management For Optimized Drug Development

Temperature Systems And Accessories

Our Biotech Success — Surrozen

Simplify Your Linker-Payload Synthesis

The Leader In Pharmaceutical, Process, And Packaging Equipment

Connect With Pharmaceutical Online: